RSCM
Rock Springs Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $41.6M | Sell |
818,206
-133,559
| -14% | -$6.8M | 2.59% | 10 |
|
2025
Q1 | $42.9M | Sell |
951,765
-519,799
| -35% | -$23.4M | 2.45% | 12 |
|
2024
Q4 | $60.8M | Sell |
1,471,564
-108,924
| -7% | -$4.5M | 2.32% | 11 |
|
2024
Q3 | $61.6M | Sell |
1,580,488
-191,550
| -11% | -$7.47M | 2.01% | 12 |
|
2024
Q2 | $60.6M | Sell |
1,772,038
-84,526
| -5% | -$2.89M | 1.82% | 14 |
|
2024
Q1 | $46.6M | Buy |
1,856,564
+5,100
| +0.3% | +$128K | 1.18% | 31 |
|
2023
Q4 | $54.7M | Buy |
1,851,464
+30,731
| +2% | +$907K | 1.35% | 24 |
|
2023
Q3 | $57.5M | Hold |
1,820,733
| – | – | 1.54% | 22 |
|
2023
Q2 | $47.1M | Buy |
1,820,733
+25,000
| +1% | +$647K | 1.12% | 30 |
|
2023
Q1 | $43.1M | Hold |
1,795,733
| – | – | 1.03% | 32 |
|
2022
Q4 | $35M | Hold |
1,795,733
| – | – | 0.84% | 42 |
|
2022
Q3 | $37.7M | Buy |
1,795,733
+78,000
| +5% | +$1.64M | 0.97% | 38 |
|
2022
Q2 | $33.4M | Buy |
1,717,733
+51,525
| +3% | +$1M | 0.97% | 36 |
|
2022
Q1 | $36.7M | Buy |
1,666,208
+127,394
| +8% | +$2.81M | 0.92% | 37 |
|
2021
Q4 | $24.5M | Buy |
1,538,814
+13,191
| +0.9% | +$210K | 0.57% | 56 |
|
2021
Q3 | $30.4M | Buy |
1,525,623
+1,900
| +0.1% | +$37.8K | 0.64% | 51 |
|
2021
Q2 | $26.3M | Buy |
1,523,723
+20,923
| +1% | +$362K | 0.52% | 58 |
|
2021
Q1 | $29.8M | Buy |
1,502,800
+6,275
| +0.4% | +$124K | 0.65% | 53 |
|
2020
Q4 | $26.1M | Buy |
1,496,525
+168,911
| +13% | +$2.95M | 0.55% | 59 |
|
2020
Q3 | $25.6M | Buy |
1,327,614
+7,704
| +0.6% | +$148K | 0.65% | 52 |
|
2020
Q2 | $25.7M | Buy |
1,319,910
+76,910
| +6% | +$1.5M | 0.7% | 53 |
|
2020
Q1 | $17.4M | Sell |
1,243,000
-2,000
| -0.2% | -$28K | 0.72% | 49 |
|
2019
Q4 | $30.5M | Buy |
1,245,000
+454,952
| +58% | +$11.2M | 0.96% | 39 |
|
2019
Q3 | $7.95M | Buy |
+790,048
| New | +$7.95M | 0.32% | 84 |
|